This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Post-Operative Treatment With Ketorolac After Abdominal Myomectomy

This study has been completed.
New York Presbyterian Hospital
Icahn School of Medicine at Mount Sinai
Information provided by:
Ascher-Walsh, Charles, M.D. Identifier:
First received: February 14, 2009
Last updated: February 17, 2009
Last verified: February 2009
The purpose of this study is to determine if ketorolac, given after abdominal myomectomy, will decrease the frequency of post-oerative fevers as well as improve post-operative pain management.

Condition Intervention
Febrile Morbidity Pain Drug: ketorolac Drug: saline

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Treatment
Official Title: Effects of Ketorolac on Post-Operative Febrile Morbidity and Pain Management in Abdominal Myomectomy Patients

Resource links provided by NLM:

Further study details as provided by Ascher-Walsh, Charles, M.D.:

Primary Outcome Measures:
  • Post-operative febrile morbidity [ Time Frame: Inital 24hrs post-operative ]

Secondary Outcome Measures:
  • Post-operative pain management [ Time Frame: Initial 24hrs post-operative ]

Enrollment: 112
Study Start Date: September 1999
Study Completion Date: August 2001
Primary Completion Date: August 2001 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: 1
Drug: saline
15mg IV every 6hrs for 4 doses
Active Comparator: 2
Drug: ketorolac
15mg IV every6 hours for 4doses
Other Name: Toradol


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Ant patient undregoing abdominal myomectomy

Exclusion Criteria:

  • Patients with contraindication to NSAIDs including history of peptic ulcer disease, renal disease, bleeding diathesis, or hypersensitivity to NSAIDS
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00845754

United States, New York
Columbia University Medical Center
New York, New York, United States, 10032
Sponsors and Collaborators
Ascher-Walsh, Charles, M.D.
New York Presbyterian Hospital
Icahn School of Medicine at Mount Sinai
  More Information

Responsible Party: Charles Ascher-Walsh MD, Mount Sinai School of Medicine Identifier: NCT00845754     History of Changes
Other Study ID Numbers: ASW 124
Study First Received: February 14, 2009
Last Updated: February 17, 2009

Keywords provided by Ascher-Walsh, Charles, M.D.:
Post-operative febrile morbidity
Post-operative pain management

Additional relevant MeSH terms:
Body Temperature Changes
Signs and Symptoms
Ketorolac Tromethamine
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Inflammatory Agents
Antirheumatic Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action processed this record on August 21, 2017